GIRAUDO, Sabrina
GIRAUDO, Sabrina
NEUROSCIENZE "RITA LEVI MONTALCINI"
Alpha-Synuclein protects SH-SY5Y cells from dopamine toxicity
2006-01-01 COLAPINTO M; MILA S; GIRAUDO S; STEFANAZZI P; MOLTENI M; ROSSETTI C; BERGAMASCO B; LOPIANO L; FASANO M
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease
2007-01-01 DI FONZO A; CHIEN HF; SOCAL M; GIRAUDO S; TASSORELLI C; ILICETO G; FABBRINI G; MARCONI R; FINCATI E; ABBRUZZESE G; MARINI P; SQUITIERI F; HORSTINK MW; MONTAGNA P; LIBERA AD; STOCCHI F; GOLDWURM S; FERREIRA JJ; MECO G; MARTIGNONI E; LOPIANO L; JARDIM LB ;O
Lymphocyte proteomics of Parkinson’s disease patients reveals cytosckeletal protein dysregulation and oxidative stress
2009-01-01 S. Mila; A. Giuliano Albo; D. Corpillo; S. Giraudo; M. Zibetti; E. M. Bucci; L. Lopiano; M. Fasano
Magnetic investigations of human mesencephalic neuromelanin
2002-01-01 BOLZONI F; GIRAUDO S; L. LOPIANO; BERGAMASCO B; FASANO M; CRIPPA PR
Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation.
2000-01-01 LOPIANO L.; FASANO M.; GIRAUDO S.; DIGILIO G.; KOENIG S.H.; TORRE E.; B. BERGAMASCO; AIME S.
Proteome analysis of human substantia nigra in Parkinson's disease.
2004-01-01 BASSO M; GIRAUDO S; CORPILLO D; BERGAMASCO B; L. LOPIANO; FASANO M
Proteome analysis of mesencephalic tissues: evidence for Parkinson's disease.
2003-01-01 BASSO M ;GIRAUDO S ;LOPIANO L ;BERGAMASCO B ;BOSTICCO E ;CINQUEPALMI A ;FASANO M
Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein.
2003-01-01 FASANO M ;GIRAUDO S ;COHA S ;BERGAMASCO B ;LOPIANO L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Alpha-Synuclein protects SH-SY5Y cells from dopamine toxicity | 2006 | COLAPINTO M; MILA S; GIRAUDO S; STEFANAZZI P; MOLTENI M; ROSSETTI C; BERGAMASCO B; LOPIANO L; FASANO M | |
| ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease | 2007 | DI FONZO A; CHIEN HF; SOCAL M; GIRAUDO S; TASSORELLI C; ILICETO G; FABBRINI G; MARCONI R; FINCATI E; ABBRUZZESE G; MARINI P; SQUITIERI F; HORSTINK MW; MONTAGNA P; LIBERA AD; STOCCHI F; GOLDWURM S; FERREIRA JJ; MECO G; MARTIGNONI E; LOPIANO L; JARDIM LB ;O | |
| Lymphocyte proteomics of Parkinson’s disease patients reveals cytosckeletal protein dysregulation and oxidative stress | 2009 | S. Mila; A. Giuliano Albo; D. Corpillo; S. Giraudo; M. Zibetti; E. M. Bucci; L. Lopiano; M. Fasano | |
| Magnetic investigations of human mesencephalic neuromelanin | 2002 | BOLZONI F; GIRAUDO S; L. LOPIANO; BERGAMASCO B; FASANO M; CRIPPA PR | |
| Nuclear magnetic relaxation dispersion profiles of substantia nigra pars compacta in Parkinson's disease patients are consistent with protein aggregation. | 2000 | LOPIANO L.; FASANO M.; GIRAUDO S.; DIGILIO G.; KOENIG S.H.; TORRE E.; B. BERGAMASCO; AIME S. | |
| Proteome analysis of human substantia nigra in Parkinson's disease. | 2004 | BASSO M; GIRAUDO S; CORPILLO D; BERGAMASCO B; L. LOPIANO; FASANO M | |
| Proteome analysis of mesencephalic tissues: evidence for Parkinson's disease. | 2003 | BASSO M ;GIRAUDO S ;LOPIANO L ;BERGAMASCO B ;BOSTICCO E ;CINQUEPALMI A ;FASANO M | |
| Residual substantia nigra neuromelanin in Parkinson's disease is cross-linked to alpha-synuclein. | 2003 | FASANO M ;GIRAUDO S ;COHA S ;BERGAMASCO B ;LOPIANO L |